Download Citation
Article Source:
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer
Erb HHH,
Bodenbender J,
Handle F,
Diehl T,
Donix L,
et al.
(2020)
Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer.
PLOS ONE 15(8): e0237248.
https://doi.org/10.1371/journal.pone.0237248